PMC:7075884 / 7958-8152 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"339","span":{"begin":174,"end":178},"obj":"Species"},{"id":"345","span":{"begin":68,"end":70},"obj":"Chemical"},{"id":"346","span":{"begin":131,"end":142},"obj":"Chemical"},{"id":"347","span":{"begin":144,"end":147},"obj":"Chemical"},{"id":"355","span":{"begin":55,"end":64},"obj":"Disease"}],"attributes":[{"id":"A339","pred":"tao:has_database_id","subj":"339","obj":"Tax:10359"},{"id":"A345","pred":"tao:has_database_id","subj":"345","obj":"MESH:C112485"},{"id":"A346","pred":"tao:has_database_id","subj":"346","obj":"MESH:D015774"},{"id":"A347","pred":"tao:has_database_id","subj":"347","obj":"MESH:D015774"},{"id":"A355","pred":"tao:has_database_id","subj":"355","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"To verify these results, we compared the inhibition of infection by GA using a plaque reduction assay (PRA) similar to the PRA for ganciclovir (GCV), the preferred antiviral HCMV drug of choice."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T39","span":{"begin":55,"end":64},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"To verify these results, we compared the inhibition of infection by GA using a plaque reduction assay (PRA) similar to the PRA for ganciclovir (GCV), the preferred antiviral HCMV drug of choice."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T105","span":{"begin":77,"end":78},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"To verify these results, we compared the inhibition of infection by GA using a plaque reduction assay (PRA) similar to the PRA for ganciclovir (GCV), the preferred antiviral HCMV drug of choice."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T175","span":{"begin":68,"end":70},"obj":"Chemical"},{"id":"T178","span":{"begin":131,"end":142},"obj":"Chemical"},{"id":"T179","span":{"begin":164,"end":173},"obj":"Chemical"},{"id":"T180","span":{"begin":179,"end":183},"obj":"Chemical"}],"attributes":[{"id":"A175","pred":"chebi_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/CHEBI_5206"},{"id":"A176","pred":"chebi_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/CHEBI_73855"},{"id":"A177","pred":"chebi_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/CHEBI_5354"},{"id":"A178","pred":"chebi_id","subj":"T178","obj":"http://purl.obolibrary.org/obo/CHEBI_465284"},{"id":"A179","pred":"chebi_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A180","pred":"chebi_id","subj":"T180","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"To verify these results, we compared the inhibition of infection by GA using a plaque reduction assay (PRA) similar to the PRA for ganciclovir (GCV), the preferred antiviral HCMV drug of choice."}

{"project":"LitCovid-sentences","denotations":[{"id":"T55","span":{"begin":0,"end":194},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"To verify these results, we compared the inhibition of infection by GA using a plaque reduction assay (PRA) similar to the PRA for ganciclovir (GCV), the preferred antiviral HCMV drug of choice."}